25th Annual National Conference- Wednesday
WEDNESDAY, OCTOBER 5, 2016 — Attending the full daily program will earn 6.0 contact hours (.6 CEUs). ACPE UAN 0860-0000-16-006-L01-P/0860-0000-16-006-L01-T
25 Years: The Biggest Changes in Health Care and What the Future May Hold, Alan Langnas, DO, Nebraska Medicine
Throughout the past quarter century, we have witnessed radical treatment advances such as the major developments in immunosuppression for organ transplantation; the public health and clinical benefits of statins; the impact of genomics on the entire field of medicine; the introduction of targeted biopharmaceuticals; the advent of oral antiviral agents for hepatitis C that are capable of cure; and the use of vaccines as cancer prevention. Additionally, the decrease of tobacco use has had a significant effect on prevention.
With cultural shifts, policy adjustments, the price of care and technological advances, the hospital industry has moved toward a more patient-empowered approach that prioritizes prevention, as it continues to evolve by streamlining and improving patient care.
Dr. Langnas will highlight the past 25 years of momentous advances and stunning innovations in health care that have ensued from the use of advanced technologies and life-saving approaches. He will also take a look down the road at what changes we may see in health care during the next decade and beyond.
A Cure for Diabetes? Innovations from Pancreas to Islet-Cell to Beta-Cell Transplantation, Dixon B. Kaufman, MD, PhD, FACS, University of Wisconsin School of Medicine and Public Health, University Hospital
The discovery of insulin transformed type 1 diabetes from a fatal disease to a manageable condition, but it remains a very serious chronic illness. Islet-cell or pancreatic transplantation can, in principle, cure type 1 diabetes, but lifelong immunosuppressive therapy is required and the lack of donor pancreas tissue has led to attempts to find alternative treatment of type 1 diabetes. This session will discuss the Clinical Islet Transplantation Consortium (CIT) study and the advances in pancreatic-islet-cell transplant and kidney/pancreas transplant. It will also explore the utility of stem-cell-derived beta cells for future treatment of diabetes and the challenges faced in developing beta-cell replacement therapies.
Developments and Advances in Medical Management of Diabetes, Anne Peters, MD, Keck School of Medicine of USC
Morbidity from diabetes involves both macrovascular (atherosclerosis) and microvascular (retinopathy, nephropathy, and neuropathy) diseases. Interventions can limit organ damage and, therefore, patients with diabetes require initial and ongoing evaluation for diabetes-related complications. Weight management and the prevention of cardiovascular morbidity is a major priority for patients with diabetes, especially type 2 diabetes mellitus (T2DM). This session will analyze why glycemic control is important in the long term to reduce the onset and severity of the complications of type 2 diabetes, as well as to reduce macrovascular risk. It will also discuss the significant metabolic benefit of medications that are used to aid in weight loss in the management of diabetes and review medical management approaches consistent with guidelines from the American Diabetes Association (ADA) for health maintenance in patients with diabetes.
Current Issues in HIV: Successes, Challenges and Epidemic Trends, Timothy Schacker, MD, University of Minnesota
The first benchmark along the continuum of human immunodeficiency virus (HIV) care is diagnosis. At the time of HIV diagnosis, patients should be evaluated to assess the stage of the disease and establish a baseline to help determine management plans and goals. Timely linkage to care following diagnosis is the next step, and the more quickly newly diagnosed individuals enter HIV care, the better their health outcomes. Antiretroviral therapy (ART) may be initiated more promptly, with a subsequent reduction in viral load, which leads to improved health outcomes and a reduction in HIV transmission. To achieve optimal clinical outcomes and to realize the potential public health benefit of treatment as prevention, attention to each step in the treatment cascade is critical. Given the many available assessment strategies and interventions, the challenge for the treatment team is to select the techniques that best fit each patient and patient population. This session will discuss how interdisciplinary teams of health care providers can address the timeliness of treatment and encourage adherence to ART, including programs in place through local and state health departments.
Relationship Between Physical and Mental Health in Children and Adolescents, Barry Sarvet, MD, The University of Massachusetts Medical School at Baystate
Medical science increasingly recognizes the vital link between physical and mental health. Consequences of adverse experiences are major risk factors for the leading causes of psychological and physical illness in children and adolescents. Adolescent psychological problems are often accompanied by physical symptoms. A prevalent mental disorder experienced among adolescents is depression, and a disturbing potential consequence of adolescent mental health disorders is the incidence of suicide. Prevention requires a comprehensive approach that influences all levels of the social ecology, including community involvement, relationships among families and neighbors, and individual behaviors. This session will identify the relationship between physical and mental health and its impact on children and adolescents.
Reducing the Burden of Heart Failure: Patient-Centered Care and Process Improvement, Michael Petty, PhD, RN, CCNS, ACNS-BC, University of Minnesota Health
According to the CDC, 5.1 million Americans are currently diagnosed with congestive heart failure (CHF) at a cost of $32 billion dollars per year. Half of these patients will die within five years of diagnosis. Despite the seriousness of this condition, health care providers struggle with how to diagnose, treat, and manage complications in patients with heart failure. During this session, Dr. Petty will review the importance of interdisciplinary teams of health care providers to effectively communicate with marginalized populations — including older adults, patients with advanced heart failure, and long-term care residents — about their prognosis, emergency situations, and advanced-care planning as forms of patient-centered care for heart failure. Treatment options for optimal management of heart failure will also be reviewed.
Hematopoietic Cell Transplant (HCT): Moving Beyond Survival — The Patient’s Perspective, Linda Burns, MD, National Marrow Donor Program (NMDP)/Be The Match; Jan Perske, Bone Marrow Transplant Recipient Mom and Caregiver; Greta Perske Hokanson, Bone Marrow Transplant Recipient; Ed Plass, Double Cord Blood Transplant Recipient; and Kate Plass, Transplant Recipient Spouse and Caregiver
HCT is a complex and costly treatment that is often the only potentially curative therapy available for patients with hematologic malignancies and genetic/immune disorders. Transplant recipients and their caregivers often experience new physical, emotional, social and financial challenges posttransplant. NMDP/Be The Match is partnering with the transplant community to better understand what matters most to recipients and caregivers and to develop a patient-reported-outcomes HCT research agenda. This unique panel session of transplant recipients and their caregivers will provide you with a very personal view into the triumphs and challenges of receiving this life-saving treatment.
- 6.00 ACPE - Pharmacists
- 6.00 ACPE - Pharmacy Technicians